Selected article for: "infection ratio and total infection ratio"

Author: Zhang, Tingting; Li, Xiao; Ji, Xiang; Lu, Jianping; Fang, Xu; Bian, Yun
Title: Generalized additive mixed model to evaluate the association between total pulmonary infection volume and volume ratio, and clinical types, in patients with COVID-19 pneumonia: a propensity score analysis
  • Cord-id: 31uljxhv
  • Document date: 2021_4_15
  • ID: 31uljxhv
    Snippet: OBJECTIVES: To investigate the association between longitudinal total pulmonary infection volume and volume ratio over time and clinical types in COVID-19 pneumonia patients. METHODS: This retrospective review included 367 patients with COVID-19 pneumonia. All patients underwent CT examination at baseline and/or one or more follow-up CT. Patients were categorized into two clinical types (moderate and severe groups). The severe patients were matched to the moderate patients via propensity scores
    Document: OBJECTIVES: To investigate the association between longitudinal total pulmonary infection volume and volume ratio over time and clinical types in COVID-19 pneumonia patients. METHODS: This retrospective review included 367 patients with COVID-19 pneumonia. All patients underwent CT examination at baseline and/or one or more follow-up CT. Patients were categorized into two clinical types (moderate and severe groups). The severe patients were matched to the moderate patients via propensity scores (PS). The association between total pulmonary infection volume and volume ratio and clinical types was analyzed using a generalized additive mixed model (GAMM). RESULTS: Two hundred and seven moderate patients and 160 severe patients were enrolled. The baseline clinical and imaging variables were balanced using PS analysis to avoid patient selection bias. After PS analysis, 172 pairs of moderate patients were allocated to the groups; there was no difference in the clinical and CT characteristics between the two groups (p > 0.05). A total of 332 patients, including 396 CT scans, were assessed. The impact of total pulmonary infection volume and volume ratio with time was significantly affected by clinical types (p for interaction = 0.01 and 0.01, respectively) using GAMM. Total pulmonary infection volume and volume ratio of the severe group increased by 14.66 cm(3) (95% confidence interval [CI]: 3.92 to 25.40) and 0.45% (95% CI: 0.13 to 0.77) every day, respectively, compared to that of the moderate group. CONCLUSIONS: Longitudinal total pulmonary infection volume and volume ratio are independently associated with the clinical types of COVID-19 pneumonia. KEY POINTS: • The impact of total pulmonary infection volume and volume ratio over time was significantly affected by the clinical types (p for interaction = 0.01 and 0.01, respectively) using the GAMM. • Total pulmonary infection volume and volume ratio of the severe group increased by 14.66 cm(3) (95% CI: 3.92 to 25.40) and 0.45% (95% CI: 0.13 to 0.77) every day, respectively, compared to that of the moderate group.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abnormality predominant pattern and acute respiratory syndrome: 1
    • absolute value and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • absolute value and lobe involvement: 1
    • absolute value and lung lesion: 1, 2
    • accurately rapidly and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and additive mixed model: 1
    • acute respiratory syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lobe involvement: 1, 2, 3, 4
    • acute respiratory syndrome and logit model: 1, 2
    • acute respiratory syndrome and longitudinal change: 1, 2
    • acute respiratory syndrome and longitudinal trajectory: 1
    • acute respiratory syndrome and lung lesion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • liver disease and lung lesion: 1, 2, 3
    • lobe involvement and lung lesion: 1, 2, 3